BioCentury
ARTICLE | Finance

Biopure Corp. (BPUR)

May 14, 2001 7:00 AM UTC

Biopure (BPUR) popped $2.76 to $30.41 on 1.1 million shares on Tuesday's news that preliminary results from a Phase III trial showed that 95% of patients receiving its Hemopure bovine hemoglobin blo...